tm
Seeing Is Believing
tm
Seeing Is Believing
Galmed Pharmaceuticals Ltd's activity chart (see below) currently has 11 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 42.59% with an average time for these price targets to be met of 432.33 days.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 24-Jul-2023. First documented stock forecast 08-Jul-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 24-Jul-2023
3 years 2 months 8 days ago
(24-Jul-2023)
1/3 (33.33%)
$2383.2 (96.22%)
89
Buy Since 12-Jun-2018
$180
$176.38 (4872.38%)
4 years 1 months 24 days ago
(08-Aug-2022)
0/2 (0%)
$98.89 (121.92%)
Buy
$13
4 years 1 months 28 days ago
(04-Aug-2022)
2/2 (100%)
$-34.55 (-72.66%)
291
Hold Since 18-May-2022
4 years 4 months 14 days ago
(18-May-2022)
1/2 (50%)
$4573.8 (144.46%)
2101
Hold
4 years 4 months 14 days ago
(17-May-2022)
1/2 (50%)
$-541.2 (-59.07%)
580
What is GLMD (Galmed Pharmaceuticals Ltd) average time for price targets to be met?
Which analyst most recently updated their price target on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst has the current lower performing score on GLMD (Galmed Pharmaceuticals Ltd) with a proven track record?
Which analyst has the most public recommendations on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most bullish on GLMD (Galmed Pharmaceuticals Ltd)?
Which analyst is the currently most reserved on GLMD (Galmed Pharmaceuticals Ltd)?
